Chargement en cours...
Simultaneous Estimation of Saxagliptin and Dapagliflozin in Human Plasma by Validated High Performance Liquid Chromatography - Ultraviolet Method
OBJECTIVES: The fixed dose combination of saxagliptin and dapagliflozin is a recently approved antidiabetic medication. It is marketed under the brand name Qtern. The aim of this study was to develop a simple, rapid, sensitive, and validated isocratic reversed phase-high performance liquid chromatog...
Enregistré dans:
| Publié dans: | Turk J Pharm Sci |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Galenos Publishing
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227962/ https://ncbi.nlm.nih.gov/pubmed/32454718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjps.galenos.2018.46547 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|